Drug Diversion Insights with Terri Vidals
By Terri Vidals
Borrow, Don't Build: A National Peer Support Toolkit for Healthcare Organizations
How can healthcare organizations better support professionals in recovery—and help them seek assistance before substance use disorder impacts their lives, patients, or careers?
In this episode of Drug Diversion Insights, Terri is joined by Kristin Waite-Labott and Dr. April Lenzmeier to discuss a powerful new resource designed to help healthcare organizations establish and strengthen peer support and recovery programs.
Kristin, who previously shared her own recovery journey on the podcast, co-chaired the IHFDA committee responsible for developing the Peer Support & Recovery Toolkit. Together with Dr. Lenzmeier, co-founder of the National Association of Peer Support for Nurses (NAPSN), they discuss how organizations can leverage existing best practices instead of building programs from scratch.
In this episode, we explore:
• Why peer support is a critical component of recovery• The importance of reaching healthcare professionals before a crisis occurs• How organizations can create recovery-friendly cultures• The value of lived experience in supporting colleagues• Common barriers to implementing peer support programs• How NAPSN is helping expand peer support resources nationwide• Practical ways healthcare organizations can use the toolkit to strengthen their programs
Download the IHFDA Peer Support & Recovery Toolkit
Whether you're a healthcare leader, diversion specialist, nurse leader, pharmacist, compliance professional, or someone passionate about workforce wellbeing, this episode offers practical guidance for building systems that support recovery while protecting patients.
Sometimes the best solution isn't to build something new—it's to borrow what's already working.
The Diversion Blind Spot Nobody Is Auditing
Most diversion analytics platforms are built to monitor controlled substance activity. That's where the regulatory focus is, and that's where most dashboards direct attention. But what if an important diversion risk is hiding in a place few people review?
In this Quick Take on Diversion Insights, Terri explores the often-overlooked world of cancel transactions and why they can represent a significant blind spot in diversion monitoring programs.
This episode covers:
• Why cancel transactions frequently go unreviewed• How non-controlled substance activity can be linked to diversion schemes• The risk of returning tampered medications to inventory• How non-controlled substances may be substituted for controlled substances• Why bedside clinical observations may not identify these events quickly• The importance of reviewing raw transaction logs, not just dashboard alerts• A real-world case where the warning signs were present in the data but initially overlooked
For diversion specialists, pharmacists, compliance professionals, medication safety teams, and healthcare leaders, this episode highlights an area that deserves greater attention in audit and monitoring strategies.
Sometimes the most important clues aren't hidden—they're simply sitting in data that no one is reviewing.
More from Rxpert Solutions:
Saving a Million Lives: Dr. Paul Lynch on Rethinking Chronic Pain and Addiction
What if the most effective way to fight the addiction crisis starts long before overdose—at the point of the very first prescription?
In this episode of Drug Diversion Insights, Terri sits down with Dr. Paul Lynch, anesthesiologist, co-founder and CEO of US Pain Care, and founder of the Treat ’Em When You Meet ’Em Foundation, to discuss a different approach to chronic pain and addiction prevention.
Dr. Lynch shares why chronic pain requires more than prescriptions alone and explains how holistic, patient-centered care can reduce unnecessary opioid exposure while improving long-term outcomes.
In this conversation, we explore:
• Dr. Lynch’s journey from anesthesiology into pain management• The three-pronged model used at US Pain Care:
- Conservative care
- Mental health integration
- Substance use treatment
This episode offers a thoughtful and hopeful perspective on the opioid crisis, emphasizing prevention, whole-person care, and earlier intervention before patients reach a crisis point.
Whether you’re a clinician, patient, family member, or healthcare leader, this conversation challenges conventional thinking around chronic pain and addiction treatment.
Caught in the Crossfire: When Trusted Colleagues Divert
What happens when the person diverting drugs in the OR is someone you trust completely—a colleague, a mentor, a friend standing right beside you at the table?
In this episode of Drug Diversion Insights, Terri sits down with Carol Davis, CRNA Emeritus, to discuss the real-world impact of diversion from the perspective of someone who lived through it firsthand.
Carol never diverted herself, but she found herself questioned, scrutinized, and caught in the fallout of colleagues whose substance use disorders led to dangerous decisions, broken trust, and risks to patient safety.
This conversation explores:• What diversion actually looks like inside the OR• How warning signs are often missed• The emotional and professional impact on innocent coworkers• The vulnerabilities that exist in healthcare systems• Why substance use disorder can remain hidden even among trusted professionals• The importance of collaboration between anesthesia and pharmacy teams
Carol also shares a strong call to action: meaningful diversion prevention depends on intentional collaboration, communication, and shared accountability across healthcare teams.
This episode is essential for anesthesia professionals, pharmacists, diversion specialists, healthcare leaders, and anyone committed to improving medication safety and patient protection.
More from Rxpert Solutions
Your Greatest Asset: How to Make Staff Your Eyes and Ears in Diversion Prevention
The most sophisticated diversion monitoring tools are only as effective as the culture surrounding them.
In this Diversion Insights Quick Take, we explore why staff engagement is one of the most important—and most overlooked—components of diversion prevention. When healthcare professionals view diversion mitigation as a program designed to protect patients and support colleagues, rather than simply punish people, they become far more likely to speak up early and participate in prevention efforts.
This episode discusses:
• Why culture matters more than surveillance alone• How fear and stigma prevent early reporting• The importance of psychological safety in healthcare• Why early identification of substance use disorder benefits everyone• How supportive programs strengthen accountability and trust• Practical ways to build staff engagement in diversion prevention
Whether you’re a nurse, pharmacist, diversion specialist, or healthcare leader, this conversation offers practical insight into creating a safer, more supportive environment for both patients and staff.
More from Rxpert Solutions:https://www.rxpert.solutions/
From Deception to Recovery: Why Healthcare Needs a Culture of Self-Reporting
What happens when addiction is hidden within a high-trust profession?
In this episode of Drug Diversion Insights, pharmacist Steve Leuck shares his personal journey through cocaine and opioid addiction while continuing to practice in healthcare. For years, he navigated systems designed to protect patients—while quietly struggling behind the scenes.
This conversation offers an honest look at how substance use can remain hidden, even in environments built on accountability and safety.
We explore:
• What fueled addiction behind the scenes• How warning signs can be missed in healthcare settings• The challenges of living a double life in a trusted role• The intervention that led to recovery• Why stigma often prevents early self-reporting• What it takes to build a culture where professionals feel safe asking for help
This episode goes beyond one individual story. It highlights a broader issue in healthcare: prevention doesn’t start with detection—it starts with creating an environment where people can come forward safely.
Whether you’re a healthcare professional, leader, or someone interested in recovery and patient safety, this is a conversation that challenges how we think about accountability, support, and culture.
More from Rxpert Solutions: https://www.rxpert.solutions/
No Software? No Problem—Conducting Effective Audits
You don’t need expensive surveillance software to start identifying diversion risk.
In this Diversion Insights Quick Take, we explore how manual auditing using ADM data can be a practical and effective way to detect early warning signs—without relying on advanced technology.
This episode focuses on simple, actionable strategies that any organization can implement to strengthen accountability and improve oversight.
In this discussion, we cover:
• How to select meaningful audit targets using existing ADM data• Why comparing “like nurses with like nurses” reveals important patterns• Identifying outliers in dispensing and waste activity• Why cancel transactions—especially on non-controlled medications—can be key red flags• Practical steps to begin or refine manual audit processes today
Manual audits may not be complex, but when done consistently and thoughtfully, they can uncover risks that might otherwise go unnoticed.
Whether you’re building a diversion monitoring program or enhancing your current approach, this episode shows how to take meaningful action—without waiting for perfect tools.
More from Rxpert Solutions: https://www.rxpert.solutions/
42 to Near Zero: A QI Approach to Anesthesia Drug Discrepancies
Are anesthesia discrepancies just documentation issues—or signals of deeper risk?
In this episode of Drug Diversion Insights, Terri sits down with Dr. Jenny Dolan, Division Chief of Pediatric Anesthesia and Director of Trauma Anesthesia at Johns Hopkins All Children’s Hospital, to discuss how her team challenged the status quo—and achieved measurable change.
Starting with 42 discrepancies per month and a 3% error rate, Dr. Dolan led a multi-year quality improvement (QI) initiative that addressed common gaps such as undocumented waste and medication removals without administration—issues that can obscure true diversion risk.
In this conversation, we explore:
• The most common drivers of anesthesia discrepancies• Why accepting discrepancies as “normal” creates risk• The seven phased interventions that led to sustained improvement• How Theory of Change guided their approach• Strategies to gain buy-in across anesthesia, pharmacy, and informatics• What meaningful, lasting change looks like in practice
This episode offers a practical roadmap for healthcare teams looking to strengthen controlled substance accountability, reduce discrepancies, and improve diversion monitoring in anesthesia settings.
More from Rxpert Solutions
Stop the Swap: Why “Integrated Waste” Is the Gold Standard for Controlled Substances
Controlled substance waste is one of the most vulnerable points in the medication-use process—and one of the most common gaps in diversion prevention programs.
In this Diversion Insights Quick Take, we explore why delayed wasting and inconsistent witnessing create opportunities for tampering and introduce uncertainty during audits. When waste processes aren’t standardized and immediate, they can compromise both patient safety and staff accountability.
This episode breaks down why integrated waste at dispense is considered the gold standard—and how it helps eliminate ambiguity at a critical control point.
In this discussion, we cover:
• Why delayed waste increases diversion risk• The pitfalls of unwitnessed or poorly documented disposal• What “integrated waste” means in practice• How proper waste workflows strengthen audit defensibility• Practical steps to improve consistency and reduce risk
Whether you're a nurse, pharmacist, diversion specialist, or healthcare leader, strengthening controlled substance waste practices is essential to building a safer, more reliable system.
More from Rxpert Solutions: https://www.rxpert.solutions/
Buprenorphine Deep Dive: Neuroscience, Safety, and Clinical Decision-Making
In this episode of Drug Diversion Insights, Terri sits down with Dr. Don Teater, a leading expert in pain management and addiction medicine, for a deeper exploration of buprenorphine—through both a clinical and neuroscience lens.
Together, they unpack what happens in the brain after opioid exposure and how those changes shape treatment decisions for patients with and without substance use disorder.
This conversation tackles some of the most complex and practical questions in addiction medicine, including:
• How opioid exposure alters brain function over time
• Differences in response between individuals with and without substance use disorder
• When to consider abstinence-based treatment vs. buprenorphine
• Whether healthcare professionals can safely return to work while on buprenorphine
• Considerations after completing abstinence-based recovery
They also explore emerging research on buprenorphine in postoperative pain management, including its safety advantages and the challenges clinicians face with dosing and efficacy in high-tolerance patients.
This is a nuanced, evidence-based discussion designed for clinicians, pharmacy leaders, opioid stewardship teams, and healthcare decision-makers navigating complex treatment and policy decisions.
More from Rxpert Solutions
https://www.rxpert.solutions/?utm_source=youtube&utm_medium=insights&utm_campaign=don_buprenorphine
CS Drips: Why Every Handoff Counts in Spotting Diversion
Controlled substance drips and PCA infusions present unique challenges when it comes to maintaining a clear chain of custody. One of the most overlooked vulnerabilities occurs during handoffs—when responsibility for these medications transfers between nurses or departments.
In this Diversion Insights Quick Take, we examine why consistent handoff practices are essential for both patient safety and diversion prevention.
Without proper documentation, volume verification, and sign-offs during shift changes or patient transfers, gaps can emerge that create confusion during audits and make it harder to identify true diversion events. These gaps can also place innocent staff under unnecessary scrutiny.
In this episode, we discuss:
• Why chain-of-custody matters for controlled substance drips and PCAs• The role of volume checks and dual sign-offs during handoffs• How poor handoff practices create blind spots in diversion monitoring• Why clear documentation protects both patients and healthcare professionals• Practical steps to strengthen protocols and improve audit clarity
Whether you're a nurse, pharmacy leader, diversion specialist, or healthcare administrator, strengthening handoff practices is a critical step toward building a more effective diversion prevention program.
More from Rxpert Solutions https://www.rxpert.solutions/?utm_source=spotify&utm_medium=quick-take&utm_campaign=iv-drips
Buprenorphine Unfiltered: Efficacy, Discontinuation, and Post-Acute Withdrawal
Few medications in addiction treatment generate as much debate as buprenorphine.
After receiving significant listener feedback describing difficult experiences with this medication—particularly around discontinuation—Terri sits down with returning guest Dr. Stuart Gitlow for a candid, science-based discussion about one of the most widely used treatments for opioid use disorder.
In this episode, we explore:
• The science behind medication for opioid use disorder (MOUD)• Why buprenorphine has helped many patients• Reported challenges with tapering and discontinuation• Post-acute withdrawal symptoms (PAWS)• The importance of informed consent and realistic expectations
This conversation does not dismiss patient experiences, nor does it ignore the life-saving role buprenorphine has played in recovery. Instead, it brings nuance to a complex issue—balancing clinical evidence with lived experience.
Whether you are a provider, patient, policymaker, or simply interested in addiction medicine, this episode offers thoughtful insight into efficacy, expectations, and long-term outcomes.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=insights&utm_campaign=buprenorphine
Med Admin Basics: A Foundation of Diversion Mitigation
When poor medication administration practices become routine, they create noise—noise that makes it nearly impossible to identify true drug diversion. Shortcuts, workarounds, and inconsistent documentation don’t just weaken compliance; they undermine safety and accountability.
In this Diversion Insights Quick Take from Rxpert Solutions, we break down why strong medication administration fundamentals are the foundation of effective diversion mitigation.
In this episode, we discuss:
How poor med admin practices obscure real diversion risk
Why setting good practice as a non-negotiable expectation matters
The role of clear policies and procedures in diversion prevention
How targeted education improves audits, monitoring, and accountability
Whether you’re a nurse, pharmacist, diversion analyst, or compliance leader, this short, focused episode reinforces a critical truth: you can’t identify diversion when basic practice is optional.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=quick_takes&utm_campaign=med_admin_basics
When Careers Hang in the Balance: Interviewing Healthcare Professionals Suspected of Diversion
Drug diversion investigations in healthcare are among the most sensitive interviews an investigator can conduct. When handled poorly, these interviews can fail to uncover the truth—and permanently damage an innocent professional’s career.
In this episode of Rxpert Solutions, I’m joined by Dave Thompson, former head of diversion investigations for a large retail pharmacy chain and current President of Wicklander-Zulawski & Associates. Dave brings decades of experience conducting high-stakes interviews where the outcomes can impact licenses, livelihoods, and lives.
We discuss why traditional pressure-based interview techniques often backfire, and how a trauma-informed, transparent, truth-focused approach leads to more reliable outcomes for both investigators and healthcare professionals.
In this conversation, you’ll learn:
Why diversion interviews carry uniquely high emotional and professional risk
How presuming guilt undermines investigations
The impact of fear, stress, and trauma on interview responses
How to balance accountability with fairness and humanity
What investigators, compliance teams, HR, and leaders should understand before conducting these interviews
This episode puts Dave in the teacher’s seat, offering practical guidance for anyone involved in diversion prevention, compliance, HR, pharmacy leadership, nursing leadership, or healthcare administration.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=insights&utm_campaign=dave_thompson
Beyond the License: What Actually Matters in Diversion Program Leadership
Should a nurse or a pharmacist lead a drug diversion program? It’s a question that comes up often—and one that misses the bigger point.
In this episode of Rxpert Solutions, we explore what truly matters in diversion program leadership beyond professional titles and credentials. The conversation was sparked by a real moment: a highly experienced diversion specialist questioning whether her nursing background caused others to doubt her qualifications to lead.
I’m joined by four diversion mitigation leaders with different professional paths:
Bethanie Gamble, pharmacy background
Mary Nelson, RN
Alecia Pittman, RN
Together, we talk candidly about credentials vs competence, the emotional and ethical weight of diversion oversight, and the skills that actually make someone effective in the lead role.
In this episode, we discuss:
The strengths nurses and pharmacists each bring to diversion leadership
Why experience, judgment, and communication matter more than job titles
Managing conflict and disagreement with stakeholders
The realities of leading high-stakes diversion programs
Whether you work in diversion prevention, pharmacy leadership, nursing leadership, compliance, or patient safety, this conversation offers valuable perspective on what effective leadership really looks like.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=youtube&utm_medium=insights&utm_campaign=diversion_specialist_role
The Propofol Problem: Why This Non-Controlled Substance Still Demands Your Attention
Propofol may not be federally classified as a controlled substance—but that doesn’t mean it’s low risk.
In this Diversion Insights Quick Take from Rxpert Solutions, we explore why propofol remains one of the most challenging medications from a diversion prevention and security perspective. Despite its non-controlled status, propofol presents serious vulnerabilities related to storage, access, and waste disposal that healthcare facilities cannot afford to ignore.
In this episode, we discuss:
Why propofol’s regulatory status creates a false sense of security
The three U.S. states that classify propofol as a controlled substance
Real-world storage and waste challenges that increase diversion risk
Why every facility—regardless of state law—needs a clear propofol strategy
Short, focused, and practical, this episode highlights how regulatory gray areas can hide some of the biggest risks in medication security.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=quick-take&utm_campaign=propofol
Securing the Unsecured: A Mayo Clinic Study on Propofol Disposal and Diversion Mitigation
Propofol is one of the most vulnerable medications for diversion in healthcare — not because it lacks abuse potential, but because it lacks the regulatory oversight applied to controlled substances.
In this episode of Rxpert Solutions, I’m joined by Michael T. Ring and Dale M. Pfrimmer to discuss their Mayo Clinic quality-improvement study published in Critical Care Nurse:
“Propofol as a Drug of Diversion: Changing Disposal Practices to Reduce Risk.”
Their work uncovered a major safety gap: before intervention, 44.1% of propofol bottles found in ICU waste bins were still full and accessible for diversion. After implementing activated carbon disposal pouches and specialized bottle-opening tools, that number dropped to zero.
We explore:
- The methodology behind their intervention
- Overcoming education and workflow challenges
- How environmental stewardship intersects with diversion prevention
- Why their success led to system-wide adoption across all ICUs and the ED
This episode highlights how simple, practical changes can meaningfully reduce diversion risk and protect healthcare professionals — even for medications outside DEA scheduling.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=insights&utm_campaign=mike-ring
How Controlled Substance Waste Impacts Pharmacy Teams
Controlled substance waste doesn’t just impact budgets — it creates a significant and measurable burden on pharmacy teams, workflows, and staffing capacity.
In this episode of Rxpert Solutions, we welcome back John Hertig and Les Louden to discuss their newest study:“Assessing Pharmacy Costs of Intravenous Push Controlled Substance Waste in Hospital-Based Areas: A Multi-Site Study”Published in the journal Pharmacy (2025).
This study is the first to quantify the pharmacy workforce costs associated with IV push controlled substance waste. It builds on years of research from John and Les, offering one of the most complete pictures to date of how waste impacts hospitals operationally and financially.
If you’ve followed their previous studies, this episode connects all the dots — revealing the true scope of waste and why it matters for every hospital in the U.S.
Thanks to our sponsor: MIDAS Healthcare Solutions
Learn more about how MidasVIEW™ safeguards patient and caregiver safety while driving compliance in controlled substance waste management: https://midashs.com/
More from Rxpert Solutions: https://www.rxpert.solutions/
Anticipatory Compounding: Navigating the FDA-DEA Divide in Hospital Pharmacies
Anticipatory compounding of controlled substances may seem like a simple operational efficiency—but it sits in a tricky regulatory space where FDA and DEA expectations don’t always align.
In this Quick Take from Rxpert Solutions, we break down what hospital pharmacies need to know to stay compliant while maintaining safe and efficient sterile compounding practices.
You’ll learn:
- How FDA and DEA interpretations differ
- Why documentation and clear internal policies are essential
- What your pharmacy must have in place before batching IVs
- Practical guidance for directors, compliance officers, and sterile compounding teams
Short, focused, and actionable—this episode gives you the clarity you need to navigate this regulatory gray zone with confidence.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=quick_take&utm_campaign=anticipatory_compounding
Culture First, Compliance Second: Rethinking Drug Diversion Prevention
What if the key to preventing drug diversion isn’t more policies—but more trust?
In this episode of Rxpert Solutions, I talk with Shealee Mitchell, M.Jur., BSN, RN, a diversion specialist who’s transforming how healthcare organizations approach drug diversion prevention through a relationship-first model.
With experience as a pharmacy tech, nurse, and Chief Experience Officer, Shealee explains why focusing on culture before compliance leads to stronger, more sustainable results.
We discuss:
- How building trust reduced missing medications
- Why “face time” beats email in prevention
- How collaboration with HR and legal strengthens accountability
- The power of celebrating wins to reinforce positive culture
This conversation challenges traditional compliance models and proves that culture—not fear—is the foundation of effective diversion prevention.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=insights&utm_campaign=shealee
Building Better Foundations: Essential Prep Work for Effective Diversion Monitoring
Before launching your diversion monitoring software, it’s crucial to make sure the foundation is strong.
In this episode of Rxpert Solutions, I’m joined by Stacy Hershman, a former diversion analyst with experience across multiple healthcare specialties, who shares her unique insights on what truly makes diversion monitoring effective.
We discuss:
- Why groundwork matters more than technology
- The risks of rushing into implementation without preparation
- How to avoid meaningless alerts and staff frustration
- Tips for new diversion analysts entering the field
Whether you’re starting or improving your diversion monitoring program, this episode will help you build a structure that actually prevents diversion—not just tracks it.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=insights&utm_campaign=hershman
Behind the Survey: Former Surveyors for The Joint Commission Share What They Really Look for in Diversion Prevention Programs
What do Joint Commission surveyors really look for when assessing your diversion prevention program?
In this episode of Rxpert Solutions, I’m joined by Marianne Sevcik, RN, MSN, of Partnership Consulting International LLC, and Meggan McGraw, MSN, CNS, RNC — both former surveyors for The Joint Commission — to share insider insights from years of conducting hospital and compliance surveys.
We explore:
- How surveyors evaluate diversion prevention program effectiveness
- The red flags and key phrases that trigger deeper review
- Balancing regulatory compliance with real-world practicality
- How to respond when you disagree with survey findings
- What surveyors think about emerging tools like AI-powered diversion monitoring
Whether you’re preparing for accreditation or refining your controlled substance diversion program, this episode gives you a rare surveyors’ perspective on how to build programs that go beyond compliance—and truly protect patients, staff, and controlled substances.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=insights&utm_campaign=surveyor
Red Flags in ADM Cancel Transactions – What Auditors Need to Know
In this Diversion Insights Quick Take from Rxpert Solutions, we spotlight an overlooked but critical issue in automated dispensing machine (ADM) monitoring — cancelled and null transactions.
These entries may look harmless in your system reports, but they can be powerful indicators of potential diversion, medication tampering, or substitution schemes.
In this short episode, you’ll learn:
- Why auditors and compliance teams must pay closer attention to cancelled transactions
- How subtle data patterns can uncover diversion risks traditional monitoring might miss
- Practical steps to improve ADM oversight and medication security
If you’re responsible for diversion monitoring, pharmacy auditing, or medication safety, this episode will help you recognize the warning signs others overlook.
More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=quick_takes&utm_campaign=cancel_transactions
Beyond Poor Practice: How to Decide When Suspicious Activity Warrants a Formal Investigation
When does “poor practice” cross the line into suspicious activity that requires a formal investigation?
In this episode of Rxpert Solutions, returning guest Denise Bruscino shares her expertise on one of the most critical decision points in diversion prevention programs: knowing when to act.
We discuss:
- Why dismissing red flags as simple mistakes can allow diversion to continue unchecked
- How committees evaluate suspicious activity and decide when to escalate
- Real-world examples of cases that appeared innocent but weren’t
- When drug testing becomes appropriate
- How culture, staff relationships, and organizational bias affect investigations
This conversation provides a decision-making framework that helps pharmacy leaders, compliance officers, and diversion teams strengthen oversight and protect both patients and controlled substances.
Thanks to our sponsor: MIDAS Healthcare Solutions
Learn more about how MidasVIEW™ safeguards patient and caregiver safety while driving compliance in controlled substance waste management: https://midashs.com/
More from Rxpert Solutions: https://www.rxpert.solutions/
Inside the OR: An Anesthesiologist's Perspective on Medication Security and Diversion Prevention
What does medication security look like in the high-stakes environment of the operating room?
In this episode of Rxpert Solutions, anesthesiologist Dr. Max Feinstein offers a unique perspective we rarely hear—how controlled substance management and diversion prevention actually play out during surgery.
Together, we explore:
- The realities of chain of custody in the OR- How pharmacy policies translate to anesthesia practice- The balance between compliance requirements and real-time patient care
- Why collaboration between pharmacy and anesthesia providers is essential
Dr. Feinstein’s frontline insights remind us that diversion prevention isn’t just about compliance—it’s about designing systems that protect patients, providers, and the integrity of care.
Thanks to our sponsor: MIDAS Healthcare Solutions
Learn more about how MidasVIEW™ safeguards patient and caregiver safety while driving compliance in controlled substance waste management: https://midashs.com/
More from Rxpert Solutions: https://www.rxpert.solutions/
Milk of Amnesia: The Joint Commission Insights on Propofol Security
Propofol—nicknamed “milk of amnesia”—isn’t a controlled substance, but it poses real addiction and diversion risks. With large bottle sizes and limited storage options, hospitals face major challenges in keeping this medication secure.
In this episode of Rxpert Solutions, I’m joined by Marianne Sevcik, a nurse with extensive Joint Commission experience and now a compliance consultant.
Together, we explore:
- Why propofol is such a gray area in regulation
- What The Joint Commission actually expects from hospitals
- Common violations involving high-risk medications
- How to respond when leadership ignores critical safety concerns
If you’ve ever struggled with propofol security, diversion prevention, or Joint Commission compliance, this conversation delivers practical insights you can apply immediately.
Thanks to our sponsor, MIDAS Healthcare Solutions
Learn more about V.I.E.W. Waste and Return System: https://midashs.com/
Learn more: https://www.rxpert.solutions/
Healing Through Stories: WisPAN Launches Their Podcast to Support Nurses in Recovery
How can storytelling create healing and connection for nurses in recovery?
In this episode of Rxpert Solutions, we welcome:
Kristin Waite-Labott, BSN, RN, CARN, CPRC – Founder & President of WisPAN (Wisconsin Peer Alliances for Nurses)
Jenny Klug, MN, RN – Vice President & Director of Social Media, WisPAN
Together, they announce the launch of the Healing Tapestry Podcast, a safe space where nurses can:
- Share personal recovery journeys
- Find peer support without stigma
- Build resilience and community
- Empower wellness in nursing culture
Kristin and Jenny share how lived experience and peer connection can transform recovery support and expand access for nurses everywhere.
Listen to the Healing Tapestry Podcast: https://open.spotify.com/show/57XorqXfwOQisLJAVKZDdt?si=yAH_d_FmRNWdAB6eWQsOAQ
Learn more: https://www.rxpert.solutions/
What Rxpert Solutions Actually Does – A Behind-the-Scenes Look at Our Services
We don’t usually take time on this podcast to talk about our own company, but after getting so many questions about what Rxpert Solutions actually does, it’s time for a dedicated episode.
In this Quick Take, I walk through our four core services:
Drug Diversion Risk Assessments – identifying vulnerabilities before they escalate
Drug Diversion Monitoring as a Service (DMaaS) – our unique outsourced monitoring model
Interview Training & Performance – strengthening investigation skills and outcomes
Program Development – building sustainable diversion prevention programs
What makes Rxpert Solutions different isn’t just what we do—it’s how we do it: blending best practices and security with real-world practicality, and keeping compassion at the center of accountability.
Whether you’re curious about outsourced diversion monitoring, improving investigation processes, or developing stronger prevention strategies, this episode gives you the answers.
🔗 Learn more: https://www.rxpert.solutions/
How to Build a Robust Diversion Program | Real Strategies, Leadership & Innovation in Healthcare
How can a suspected diversion case become the spark for lasting innovation?
In this episode of Rxpert Solutions, three healthcare leaders from a DC metro hospital share how they built a robust diversion program that goes beyond policies and procedures.
Guests:
Jen Raynor – Director of Pharmacy
Jeri Yeman – Quality, Safety & Regulatory Compliance Manager & Medication Safety Officer
Jason Ramos – Regulatory Compliance Coordinator
They reveal how:
- Leadership buy-in was secured to support prevention efforts
- A real diversion case was used to refine monitoring algorithms in real time
- Evolving roles in safety and compliance strengthened the program
- Continuous improvement became part of their culture
This episode is essential for healthcare professionals, compliance teams, and leaders working to advance medication security and patient safety.
Learn more: https://www.rxpert.solutions/
Speaking Out Safely: Legal Considerations for Healthcare Professionals Sharing Recovery Stories
In this Quick Takes episode from Rxpert Solutions, we explore an often-overlooked question: Is it legally safe for healthcare professionals to share their recovery stories?
After a healthcare professional in long-term recovery declined to be a guest due to fears of legal repercussions—despite completing their state’s recovery process years ago—we take a closer look at the legal landscape of public disclosure.
For more information on drug diversion mitigation and resources, visit https://www.rxpert.solutions/
Data Without Dialogue: A Dangerous Shortcut in Diversion Investigations
In this Quick Take, I'm addressing a concerning trend I'm seeing across healthcare facilities - the practice of concluding diversion investigations based solely on software analytics and audit data, without ever speaking to the healthcare professional involved.
Too many facilities are looking at their monitoring reports, conducting deep-dive audits of documentation and waste records, and then making a determination that unusual patterns are simply "practice issues" rather than potential diversion. But here's the problem: you can't possibly know that without having a conversation with the individual.
This shortcut approach creates significant safety risks and misses opportunities to identify both actual diversion and legitimate practice concerns that need addressing. Every facility needs to evaluate their investigation process and ask themselves: who is making the decision about whether to interview staff, and what criteria are they using?
The interview process doesn't have to be adversarial or make staff feel targeted. When done correctly, it's simply a professional conversation to understand the full picture behind the data. But skipping this critical step entirely? That's a gap that puts both patients and facilities at risk.
Missing from the Table: Infection Prevention's Role in Diversion Response
Welcome back to the show. Today we're diving into a critical but often overlooked aspect of drug diversion investigations - the role of infection prevention. While most facilities focus on the regulatory and criminal justice aspects of diversion cases, there's a vital public health component that frequently gets pushed to the sidelines until it's too late.
My guest today is Michelle Nation, a nurse with extensive experience in infection prevention. Michelle has witnessed firsthand how the disconnect between diversion response teams and infection prevention departments can leave patients at risk and facilities scrambling to address preventable outbreaks. She's been advocating for a more integrated approach that brings infection prevention expertise to the table from day one of any diversion investigation.
While we've all read about the serious cases documented on the CDC website where infection prevention ultimately played a crucial role, by then the damage was often already done. In this episode, we explore how facilities can bridge this gap proactively, what the patient notification process should look like, and why every diversion response team needs an infection preventionist at the table from the very beginning.
Beyond Diversion: Understanding Medical Record Falsification in Healthcare
In this episode, we delve into the often-overlooked issue of medical record falsification and its serious implications for healthcare facilities, professionals, and patients. My guest, Tracy Hunt, shares her expertise on this complex topic, examining how falsified documentation intersects with medication diversion, insurance fraud, and legal accountability.
Tracy explores the statutory definitions of falsification, potential criminal charges, and the complications of bundled medication charges in billing systems. Our discussion covers discovery methods for identifying suspicious patterns, the investigation process when concerns arise, and what happens when cases are escalated.
Whether you're a healthcare administrator, compliance officer, or clinical professional, this episode offers valuable insights into protecting your practice, your patients, and your career from the serious consequences of documentation fraud. Join us for this important conversation about maintaining integrity in healthcare documentation and billing practices.
The Art of Investigative Interviewing: Insights from a Healthcare 'Unicorn'
Welcome to today's episode where we explore the nuanced world of investigative interviewing in healthcare settings. My guest is Denise Bruscino, the Chief Diversion Officer at Moffitt Cancer Center in Florida. With a unique combination of nursing experience in inpatient settings and specialized training in behavioral analysis, Denise brings a rare perspective to healthcare investigations—hence her apt self-description as a "unicorn" in her field.
In this enlightening conversation, Denise shares her expertise on developing effective interviewing techniques, training others in the art of investigation, and the delicate balance between clinical knowledge and interview skills. We discuss the importance of flexibility during interviews, preparation strategies for managers, and practical advice for organizations building their own interview programs.
Whether you're in healthcare, compliance, human resources, or any field that requires skilled interviewing, Denise's insights offer valuable guidance for conducting meaningful and effective investigations.
Protecting Your Practice: A Compliance Expert's Guide to Corresponding Responsibility
Welcome to today's episode where we dive deep into one of the most critical yet often misunderstood areas of healthcare compliance: corresponding responsibility. I'm joined by Michael Staples, a healthcare regulatory compliance expert whose fascinating journey from law enforcement detective to compliance specialist gives him a unique perspective on this complex topic.
n our conversation, Mike highlights a troubling reality: regulatory agencies often fail to distinguish between innocent mistakes and criminal intent, leaving non-criminal healthcare professionals fighting their cases in court where juries must apply common sense to see the truth. He shares practical directives for both pharmacists and physicians to protect themselves while fulfilling their professional obligations.
Whether you're a healthcare provider, pharmacist, or compliance officer, this episode offers clarity on navigating the complex landscape of corresponding responsibility. So stay tuned for this informative discussion that could help protect your practice and your patients.
New Hires Surprised by Controlled Substance Accountability
In this Diversion Insights Quick Take, I examine an intriguing comment I heard recently while discussing missing medications with a client. New nurse hires from across the country consistently express surprise at how seriously this facility takes controlled substance management compared to their previous workplaces. Join me for this 5-minute discussion about what this reveals about the inconsistency in hospital protocols nationwide and why robust controlled substance oversight should be the standard, not the exception.
Industry Shakeup: Bluesight's Acquisition of Protenus and What It Means for Customers
In today's podcast, I'm discussing a significant development in the healthcare compliance technology sector. Bluesight's recent acquisition of Protenus has created waves of concern among Protenus customers who now face an unexpected transition. While many were satisfied with their Protenus diversion software solutions, they're now being required to switch to Bluesight's platform. These customers are navigating negotiations with a new company while managing this mandated change. I'll share insights on why this matters, what customers are experiencing, and what options might be available moving forward in this rapidly consolidating industry.
Listen in for a 5-minute exploration of this timely topic that's affecting healthcare compliance departments across the industry.
A Compassionate Approach to Neonatal Abstinence Syndrome: Conversation with Tara Sundem
In this episode, I speak with Tara Sundem, Co-founder of Hushabye Nursery, about their innovative approach to caring for infants with neonatal abstinence syndrome.
Tara shares how Hushabye's specialized environment differs from traditional NICU settings, creating better outcomes for both babies and families experiencing the challenges of substance use disorders. We discuss their holistic, family-centered care model, impressive results, and Tara offers valuable insights for healthcare professionals working with patients affected by substance use disorders.
Join us for this enlightening conversation about compassionate, effective healthcare solutions that support both vulnerable infants and their families during a critical time.
Confronting the Hidden Costs of Medication Waste in Hospital Settings
Our guests: "Les Louden, PharmD, MS, Pharmacy Manager St. Joseph's Hospital BayCare Health System, and John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP Founder, Hertig Healthcare Advising, Adjunct Assistant Professor, Purdue University.
In this episode, I welcome back Dr. John Hertig along with first-time guest Les Louden from BayCare Health System to discuss their groundbreaking research on controlled substance waste in hospital procedural areas.
Their recent study, ""Assessing the Costs of Intravenous Push Waste in Intraoperative Areas Through Observation,"" reveals striking findings about both the financial and operational impact of medication waste. We explore how commonly used medications like fentanyl, hydromorphone, morphine, midazolam, and ketamine are routinely wasted in significant quantities.
John and Les discuss how their multi-site study quantified not just product waste but also the substantial ""workforce time waste"" associated with medication disposal processes. With an estimated $56,557 worth of medication and staff time wasted annually at just the hospitals studied, our conversation examines the practical implications for healthcare systems nationwide.
We also delve into potential solutions, including automated workflows that significantly reduce documentation time, manufacturer considerations for right-sized medication packaging, and the patient safety implications when clinical staff are pulled away from care to witness waste disposal.
Whether you're a healthcare administrator, pharmacy professional, or clinician, this evidence-based discussion offers valuable insights into an often overlooked aspect of healthcare efficiency and resource management.
Thanks to our sponsor, MIDAS Healthcare SolutionsLearn more about V.I.E.W. Waste and Return System: https://midashs.com/products/
For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/
When Surveyors Dig Deeper: The Shift Toward Meaningful Diversion Programs
Our guest: Hossam Gamal, PharmD, BCPS, MBAWelcome to Drug Diversion Insights. In today's episode, we're diving into a critical conversation about hospital drug diversion programs and the evolving landscape of regulatory oversight. I'm joined by Dr. Hossam Gamal, an experienced Pharmacy Director who brings valuable insights into how surveyors are increasingly scrutinizing diversion mitigation efforts.Recent trends suggest a significant shift in how facilities are being evaluated - moving beyond simply checking boxes to requiring truly meaningful diversion programs. Dr. Gamal will share his firsthand experiences with recent surveys, discussing how regulators are examining program effectiveness, the role of monitoring software, and the essential components of a robust diversion response strategy.We'll explore whether surveyors are equipped with the necessary technical knowledge to evaluate these programs effectively, drawing parallels to similar challenges faced in other areas of healthcare compliance. Of particular interest is Dr. Gamal's perspective on establishing clear criteria for activating diversion response teams - a critical yet often overlooked aspect of comprehensive diversion mitigation.This conversation comes at a crucial time when healthcare facilities nationwide are reevaluating their approach to diversion mitigation. Whether you're a healthcare administrator, pharmacy professional, or compliance officer, today's discussion will provide valuable insights into creating and maintaining effective diversion programs that meet increasingly rigorous regulatory expectations.Thanks to our sponsor, MIDAS Healthcare SolutionsLearn more about V.I.E.W. Waste and Return System: https://midashs.com/products/For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/#drugdiversion #hospitalpharmacy #opioidcrisis #hospitalworker
Healthcare Tech Evolution: Bluesight's Growth and Vision for Diversion Monitoring
Welcome to today's episode focused on healthcare technology and diversion monitoring. Our guest is Lauren Forni, Senior Director of Clinical Strategy at Bluesight, a company making significant moves in the healthcare technology space through strategic acquisitions, including their recent purchase of Protenus.
In this episode, we explore Bluesight's expansion strategy, the future of their Control Check diversion monitoring platform, and how they plan to integrate newly acquired technologies. Lauren shares insights on maximizing the benefits of Control Check software and discusses how healthcare facilities can optimize their diversion monitoring workflows.
For healthcare leaders concerned about regulatory compliance and diversion prevention, this conversation offers valuable perspectives on how technology is evolving to meet these critical challenges.
Stay tuned for a deep dive into the future of diversion monitoring technology and Bluesight's vision for transforming healthcare compliance and safety.
Telemedicine Buprenorphine: Expanding Access to Opioid Use Disorder Treatment
In today's episode, we explore the evolving landscape of buprenorphine prescribing through telemedicine with Dr. Stuart Gitlow, a distinguished expert in addiction medicine. Dr. Gitlow returns to discuss the Biden administration's new ruling that enables providers to prescribe buprenorphine via telehealth, including audio-only visits, without requiring initial in-person evaluation.
Building on our previous conversation about the elimination of the DATA waiver, we examine how physicians have responded to these expanded prescribing capabilities. Dr. Gitlow shares insights from his extensive experience with telemedicine during COVID-19 and addresses the implications of allowing 6-month prescriptions through virtual visits.
We also discuss critical aspects of this new framework, including pharmacy verification requirements and the role of emergency departments in initiating buprenorphine treatment. Join us for this timely conversation about expanding access to addiction treatment while maintaining appropriate safeguards and quality of care.
For listeners new to our series, we recommend listening to our earlier episode "History and the Elimination of the DATA Waiver" featuring Dr. Gitlow, where we explored the historical context of addiction treatment regulations.
Legal Preparedness in Healthcare: A Conversation with Ronald Chapman II
In today's episode we explore crtical issues in healthcare compliance and regulation. Join me in a fascinating conversation with Attorney Ronald Chapman II, a distinguished healthcare law specialist whose work I first discovered through his thought-provoking article 'Shielding Physicians: The Untold Story of Legal Preparedness.'
Ron brings unique insights from his extensive experience representing healthcare providers across multiple states, and today we're diving deep into the intersection of healthcare compliance and legal defense. We'll explore everything from proactive compliance strategies to the complexities of DEA regulations, and even tackle the challenging ethical questions surrounding suspected drug diversion in healthcare settings.
Whether you're a healthcare administrator, compliance officer, or medical professional, this conversation offers valuable perspectives on protecting your practice while maintaining regulatory compliance. Ron shares his expertise not only as a legal defender but also as a consultant helping healthcare organizations build robust compliance systems.
Get ready for an enlightening discussion that bridges the gap between legal theory and practical healthcare compliance.
Minding Our Own Store: Pharmacy-Based Drug Diversion
Drug diversion monitoring in healthcare often focuses heavily on nursing units, but what about diversion within the pharmacy itself? In this episode, Heidi Bragg, Drug Diversion Specialist at Texas Children's Hospital, shares compelling cases and insights about pharmacy-based diversion. Drawing from her extensive pharmacy experience, Heidi discusses why we must 'mind our own store' and remain vigilant about diversion risks within pharmacy departments. Through real-world examples and professional expertise, this conversation between two pharmacists highlights critical blind spots in traditional diversion monitoring approaches and emphasizes the importance of comprehensive pharmacy surveillance.
Cross-Border Perspectives: Drug Diversion in Canadian Healthcare
Drug diversion in healthcare settings is a challenge that crosses borders, affecting facilities worldwide. Today, we gain valuable insights into how our neighbors to the north approach this critical issue.
Our guest is Neil Braun, currently serving as the Senior Director of Provincial Health Services Authority Allied Health Professional Practice. Neil previously served as the Drug Diversion Lead for Fraser Health Authority, where he played a pivotal role in developing and implementing a comprehensive drug diversion program that has since become a model for other Canadian health systems.
In this episode, we'll explore the evolution of drug diversion monitoring in Canadian healthcare, from a watershed moment in 2015 that catalyzed change, through the development of a multisectoral collaborative approach that Neil documented in his published article Establishing a Multisectoral Collaborative Drug Diversion Program in a Canadian Health System.
Through our conversation, we'll discover both the similarities and unique differences between Canadian and U.S. approaches to diversion prevention, offering valuable perspectives for healthcare professionals on both sides of the border.
Join us as Neil shares his expertise and insights from building a diversion program within Canada's publicly funded universal healthcare system, and learn how his team's innovative approach has helped shape drug diversion prevention in Canadian healthcare.
When the Healer Needs Healing: A Doctor's Path to Recovery
Our guest: Stephen Loyd, MD, Chief Medical Officer at Cedar Recovery In this powerful episode, we sit down with Dr. Stephen Loyd, whose journey from active addiction to recovery has become a beacon of hope in healthcare. Twenty years into his recovery, Dr. Loyd candidly shares his personal story of substance use disorder during his medical residency and the pivotal moment that led to his confession and transformation. From struggling in silence to becoming a prominent voice in addiction medicine and policy reform, Dr. Loyd offers unique insights into why healthcare professionals often go unnoticed in their struggle with substance use. He addresses the critical questions of how to recognize warning signs, approach colleagues with concern, and create meaningful change in healthcare systems. This conversation goes beyond the typical recovery narrative, diving deep into practical strategies for intervention, the consequences of coming forward, and the path to rebuilding a medical career. Dr. Loyd's transformation from practicing internal medicine to becoming a leading advocate for policy change demonstrates how personal challenges can evolve into powerful forces for systemic improvement. Join us for this honest, enlightening discussion about addiction in healthcare, the importance of early intervention, and the ongoing journey of recovery. Whether you're a healthcare professional, someone in recovery, or interested in understanding substance use disorder better, this episode offers valuable insights and hope. For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/ #drugdiversion #hospitalpharmacy #opioidcrisis #hospitalworker
The Sweet Connection: Linking Sugar and Drug Use Disorders
Our guest: Michael Collins, Founder & CEO SugarAddiction.com The landscape of substance use disorders is complex and multifaceted, often extending beyond what we traditionally consider addictive substances. Today, we're expanding our usual focus on pharmaceutical diversion to explore an intriguing connection in the world of substance use disorders. Our guest is Michael Collins, Founder and CEO of SugarAddiction.com, whose personal journey through recovery led him to investigate the compelling parallels between alcohol use disorders and sugar addiction. As we'll discover, the brain's response to different substances - whether they're controlled medications, alcohol, or even sugar - may share more commonalities than we might expect. In this episode, we'll explore how sugar affects our brain chemistry, examine potential correlations between various types of substance use disorders, and challenge our preconceptions about addiction. Michael brings a unique perspective, combining personal experience with extensive research and work in supporting those struggling with sugar use disorder. Together, we'll investigate whether having one type of substance use disorder might predispose someone to another, and examine how trauma plays a role in these complex relationships. We'll also discuss why society might readily acknowledge certain substance use disorders while minimizing or dismissing others. Join us for this fascinating conversation that bridges the gap between traditional substance use disorders and what some researchers are now calling 'food addiction,' as we challenge our understanding of substance use disorder itself. This is the link for the QuitSugarSummit discussed in the podcast: https://quitsugarsummit.com/2024-quit-sugar_summit_registration For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/
Optimizing Controlled Substance Waste: Research Insights from the Field
When it comes to controlled substance management in healthcare facilities, waste optimization plays a crucial role in both cost savings and diversion prevention. In this episode of Drug Diversion Insights, we dive deep into groundbreaking research on optimizing controlled substance waste with two innovative pharmacists.
Tyler Cramer, an inpatient clinical pharmacist at Boone Health in Missouri, shares insights from his AJHP-published research on maximizing opioid stewardship through fentanyl vial size optimization. Joining him is Kayla Sewell, a PGY2 Pharmacy Informatics Resident at Lifepoint, who recently presented her analysis of financial and workforce impacts of controlled substance waste at IHFDA.
Our guests explore:
The catalysts behind their research initiatives
Different approaches to studying waste optimization
Key findings and their practical implications
Implementation strategies and lessons learned
Integration of waste optimization into diversion prevention programs
Their research provides valuable insights for healthcare facilities looking to enhance both fiscal responsibility and diversion prevention through waste management strategies.
Whether you're a pharmacy leader, compliance officer, or healthcare administrator, this discussion offers practical takeaways for optimizing your controlled substance management program.
Christie Moon on Balancing Compliance, Employee Rights & Safety in Drug Diversion Investigations
Our guest: Christie Moon JD, CHC. Moon Compliance Consulting Drug diversion in healthcare facilities remains one of the most complex challenges facing hospitals today. In our latest podcast episode, we sit down with Christie Moon, founder of Moon Compliance Consulting, LLC and an attorney specializing in healthcare compliance. With extensive experience helping facilities navigate diversion investigations, Christie shares critical insights on common missteps hospitals make when handling suspected diversion cases. From the crucial first steps following a diversion alert to managing the intricate web of regulatory requirements from the DEA, Boards of Pharmacy, and licensing boards, Christie breaks down the essential elements of an effective response. She also addresses the delicate balance hospitals must strike between protecting employee rights and maintaining patient safety when investigating potential diversion. Listen as we explore practical strategies for: Immediate actions following a diversion alert Coordinating investigations across multiple regulatory bodies Protecting both employee and patient interestsBuilding an effective diversion response program This episode provides valuable guidance for healthcare leaders looking to strengthen their facility's approach to handling suspected diversion cases. Thanks to our sponsor, MIDAS Healthcare Solutions Learn more about V.I.E.W. Waste and Return System: https://midashs.com/products/” For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/#drugdiversion #hospitalpharmacy #opioidcrisis #hospitalworker Facebook: / rxpertsolutions X: / rxpertsolutions Linkedin: / rxpertsolutions Spotify: https://open.spotify.com/show/6UwSCi8...
Legacy of Leadership: A Conversation with IHFDA's John Burke
Our guest: John Burke
Executive Director IHFDA
Healthcare facility drug diversion affects patient safety, employee well-being, and community health. Few people understand this better than today's guest, John Burke, who has dedicated his career to combating this critical issue. As one of the founding members and current Executive Director of the International Health Facility Diversion Association (IHFDA), John has been instrumental in shaping how healthcare organizations address drug diversion.
Since its establishment in 2015, IHFDA has grown into a pivotal organization under John's leadership, bringing together healthcare security, pharmacy, nursing, and law enforcement professionals to tackle the complex challenge of drug diversion in healthcare settings.
As John prepares to retire from his position as Executive Director at the end of this year, we have the privilege of sitting down with him to explore not just the origins of IHFDA, but the personal journey that led him to become such an influential figure in healthcare diversion prevention. Today's conversation offers a unique glimpse into the experiences, challenges, and insights that have shaped both John's career and the evolution of healthcare diversion prevention.